Founder of TiGenix NV, Gil Beyen presently is Executive Chairman for Erytech Pharma, Inc. and Co-Managing Director at Axxis V&C BVBA. Mr. Beyen is also Commissioner at Vlaams Instituut voor Biotechnologie - Flanders Institute and on the board of 6 other companies.

In his past career Mr. Beyen occupied the position of MD, Executive Director & Chief Business Officer at TiGenix NV, Head-Life Sciences Division at Arthur D. Little, Inc. and Head-Life Sciences Division at Arthur D. Little Benelux NV (a subsidiary of Arthur D. Little, Inc.), Chief Executive Officer & Director at ERYTech Pharma SA and Manager at Gil Beyen BVBA.

He received an MBA from The University of Chicago, a graduate degree from Université Catholique de Louvain and a graduate degree from Katholieke Universiteit Leuven.